Answers are grounded in this paper and cite their sources.
In dogs the expandable, solid-solution fibrous dosage form enhanced the bioavailability of the sparingly-soluble model drug nilotinib three-fold compared with the present crystalline drug particle-filled capsules.
No takes yet. Share an insight, caveat, or question.
Blaesi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: